EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE )

Rozalyn L Rodwin iD, Fang Wang, Lu Lu, Zhenghong Li, Deo Kumar Srivastava, Nicholas S Phillips, Raja B Khan, Tara M Brinkman, Kevin R Krull, Frederick A Boop, Gregory T Armstrong, Thomas E Merchant und 5 weitere

Cancer Medicine · 2024-07 · 13 (14)

DOI: 10.1002/cam4.7422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 26.07.2024. Verfasst von Rozalyn L Rodwin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Cancer Survivors, Quality of Life. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Lebanese Syrian Associated Charities, Cancer Center Support Grant, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Survivors of childhood central nervous system (CNS) tumors can develop motor and sensory impairment from their cancer and treatment history. We estimated the prevalence of motor and sensory impairment in survivors compared with controls through clinical assessment and identified associated treatment exposures and functional, quality of life (QOL), and social outcomes.

Methods

Survivors of childhood CNS tumors from the St. Jude Lifetime Cohort ( n = 378, median [range] age 24.0 [18.0–53.0] years, 43.4% female) ≥5 years from diagnosis and controls ( n = 445, median [range] age 34.0 [18.0–70.0] years, 55.7% female) completed in‐person evaluation for motor and sensory impairment using the modified Total Neuropathy Score. Impairment was graded by modified Common Terminology Criteria for Adverse Events. Multivariable models estimated associations between grade ≥2 motor/sensory impairment, individual/treatment characteristics, and secondary outcomes (function by Physical Performance Test, fitness by physiologic cost index, QOL by Medical Outcomes Survey Short Form‐36 physical/mental summary scores, social attainment).

Results

Grade ≥2 motor or sensory impairment was more prevalent in survivors (24.1%, 95% Confidence Interval [CI] 19.8%–29.4%) than controls (2.9%, CI 1.4–4.5%). Among survivors, in multivariable models, motor impairment was associated with vinca exposure 2036 mg/m 2 versus none (OR 12.61, CI 2.19–72.72). Sensory impairment was associated with older age at diagnosis (OR 1.09, CI 1.01–1.16) and craniospinal irradiation versus none (OR 4.39, CI 1.68–11.50). There were lower odds of motor/sensory impairment in survivors treated in the year 2000 or later versus before 1990 (Motor: OR 0.29, CI 0.10–0.84, Sensory: OR 0.35, CI 0.13–0.96). Motor impairment was associated with impaired physical QOL (OR 2.64, CI 1.22–5.72).

Conclusions

In survivors of childhood CNS tumors, motor and sensory impairment is prevalent by clinical assessment, especially after exposure to etoposide, vinca, or craniospinal radiation. Treating motor impairment may improve survivors' QOL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsCancer SurvivorsQuality of LifeHumansFemaleMaleAdolescentAdultYoung AdultMiddle AgedChildPrevalenceCohort StudiesSensation DisordersAged

Stichwörter der Autor:innen

central nervous system tumorchildhood cancercranial radiationetoposidemotor impairmentperipheral neuropathyplatinumquality of lifesensory impairmentsurvivorshipvinca alkaloid

Autor:innen und Institutionen

  • Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Yale Cancer Center, New Haven, Connecticut, USA.
  • Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Psychology and Behavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

ORCID-Profile: Rozalyn L Rodwin

Förderung

  • American Lebanese Syrian Associated Charities
  • Cancer Center Support Grant
  • NCI NIH HHS
  • NCATS NIH HHS
  • COVID-19 Fund to Retain Clinical Scientists at Yale, sponsored by the Doris Duke Charitable Foundation award # 2021266, and the Yale Center for Clinical Invest…
  • William O. Seery Mentored Research Award for Cancer Research, Bank of America, N.A., Trustee
  • Hyundai Hope On Wheels
  • National Cancer Institute

Zitieren

APA

Rodwin, R. L., Wang, F., Lu, L., Li, Z., Srivastava, D. K., Phillips, N. S., Khan, R. B., Brinkman, T. M., Krull, K. R., Boop, F. A., Armstrong, G. T., Merchant, T. E., Gajjar, A., Robison, L. L., Hudson, M. M., Kadan-Lottick, N. S., & Ness, K. K. (2024). Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE ). Cancer Medicine, 13(14). https://doi.org/10.1002/cam4.7422

Vancouver

Rodwin RL, Wang F, Lu L, Li Z, Srivastava DK, Phillips NS, et al. Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE ). Cancer Medicine. 2024;13(14). doi:10.1002/cam4.7422

BibTeX
@article{Rodwin2024,
  author = {Rodwin, Rozalyn L and Wang, Fang and Lu, Lu and Li, Zhenghong and Srivastava, Deo Kumar and Phillips, Nicholas S and Khan, Raja B and Brinkman, Tara M and Krull, Kevin R and Boop, Frederick A and Armstrong, Gregory T and Merchant, Thomas E and Gajjar, Amar and Robison, Leslie L and Hudson, Melissa M and Kadan-Lottick, Nina S and Ness, Kirsten K},
  title = {Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE )},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  doi = {10.1002/cam4.7422}
}
Kostenlos starten →